| Gene Ontology term | Cluster frequency | Protein frequency of use | P-value |
|---|
| actin-myosin filament sliding | 3 out of 40 genes, 7.5% | 4 out of 533 genes, 0.8% | 0.001492378 |
| actin-mediated cell contraction | 3 out of 40 genes, 7.5% | 4 out of 533 genes, 0.8% | 0.001492378 |
| regulation of hydrolase activity | 7 out of 40 genes, 17.5% | 26 out of 533 genes, 4.9% | 0.001787814 |
| positive regulation of hydrolase activity | 5 out of 40 genes, 12.5% | 15 out of 533 genes, 2.8% | 0.003183325 |
| muscle system process | 3 out of 40 genes, 7.5% | 5 out of 533 genes, 0.9% | 0.003536028 |
| muscle contraction | 3 out of 40 genes, 7.5% | 5 out of 533 genes, 0.9% | 0.003536028 |
| activation of cysteine-type endopeptidase activity involved in apoptotic process | 2 out of 40 genes, 5.0% | 2 out of 533 genes, 0.4% | 0.005501559 |
| regulation of blood pressure | 2 out of 40 genes, 5.0% | 2 out of 533 genes, 0.4% | 0.005501559 |
| gas transport | 2 out of 40 genes, 5.0% | 2 out of 533 genes, 0.4% | 0.005501559 |
| ruffle organization | 2 out of 40 genes, 5.0% | 2 out of 533 genes, 0.4% | 0.005501559 |
| negative regulation of endocytosis | 2 out of 40 genes, 5.0% | 2 out of 533 genes, 0.4% | 0.005501559 |
| activation of cysteine-type endopeptidase activity | 2 out of 40 genes, 5.0% | 2 out of 533 genes, 0.4% | 0.005501559 |
| actin filament-based movement | 3 out of 40 genes, 7.5% | 6 out of 533 genes, 1.1% | 0.006703428 |
| positive regulation of catalytic activity | 7 out of 40 genes, 17.5% | 34 out of 533 genes, 6.4% | 0.009248951 |
| actin filament-based process | 5 out of 40 genes, 12.5% | 19 out of 533 genes, 3.6% | 0.009826081 |
| positive regulation of molecular function | 8 out of 40 genes, 20.0% | 43 out of 533 genes, 8.1% | 0.01005013 |
| regulation of catalytic activity | 9 out of 40 genes, 22.5% | 52 out of 533 genes, 9.8% | 0.01013461 |
| reproduction | 9 out of 40 genes, 22.5% | 55 out of 533 genes, 10.3% | 0.01475287 |
| pyrimidine nucleobase metabolic process | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| pyrimidine nucleobase catabolic process | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| response to unfolded protein | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| regulation of heart contraction | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| fertilization | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| muscle filament sliding | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| nucleobase catabolic process | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| muscle organ morphogenesis | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| cardiac muscle tissue development | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| cardiac muscle tissue morphogenesis | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| muscle tissue morphogenesis | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| pyrimidine-containing compound catabolic process | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| positive regulation of cysteine-type endopeptidase activity | 2 out of 40 genes, 5.0% | 3 out of 533 genes, 0.6% | 0.01571726 |
| pyrimidine-containing compound metabolic process | 3 out of 40 genes, 7.5% | 8 out of 533 genes, 1.5% | 0.01687047 |
| regulation of molecular function | 10 out of 40 genes, 25.0% | 66 out of 533 genes, 12.4% | 0.01715658 |
| cell adhesion | 6 out of 40 genes, 15.0% | 30 out of 533 genes, 5.6% | 0.01871315 |
| biological adhesion | 6 out of 40 genes, 15.0% | 30 out of 533 genes, 5.6% | 0.01871315 |
| actin cytoskeleton organization | 4 out of 40 genes, 10.0% | 15 out of 533 genes, 2.8% | 0.02033055 |
| viral infectious cycle | 5 out of 40 genes, 12.5% | 23 out of 533 genes, 4.3% | 0.02267741 |
| reproductive process | 8 out of 40 genes, 20.0% | 50 out of 533 genes, 9.4% | 0.02489284 |
| cellular process involved in reproduction | 6 out of 40 genes, 15.0% | 32 out of 533 genes, 6.0% | 0.02547565 |
| translation | 8 out of 40 genes, 20.0% | 51 out of 533 genes, 9.6% | 0.02787323 |
| viral reproduction | 7 out of 40 genes, 17.5% | 42 out of 533 genes, 7.9% | 0.02930499 |
| multi-organism cellular process | 7 out of 40 genes, 17.5% | 42 out of 533 genes, 7.9% | 0.02930499 |
| regulation of response to biotic stimulus | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| heart morphogenesis | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| circulatory system process | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| heart process | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| RNA export from nucleus | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| blood circulation | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| positive regulation of endopeptidase activity | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| positive regulation of peptidase activity | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| myofibril assembly | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| actomyosin structure organization | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| response to topologically incorrect protein | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| ribosomal small subunit biogenesis | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| heart contraction | 2 out of 40 genes, 5.0% | 4 out of 533 genes, 0.8% | 0.02994214 |
| tissue development | 4 out of 40 genes, 10.0% | 17 out of 533 genes, 3.2% | 0.03173912 |
| regulation of peptidase activity | 3 out of 40 genes, 7.5% | 10 out of 533 genes, 1.9% | 0.03251096 |
| regulation of endopeptidase activity | 3 out of 40 genes, 7.5% | 10 out of 533 genes, 1.9% | 0.03251096 |
| single-organism transport | 12 out of 40 genes, 30.0% | 94 out of 533 genes, 17.6% | 0.03297442 |
| multi-organism process | 8 out of 40 genes, 20.0% | 54 out of 533 genes, 10.1% | 0.03831854 |
| cellular component movement | 6 out of 40 genes, 15.0% | 35 out of 533 genes, 6.6% | 0.03844794 |
| cell activation | 3 out of 40 genes, 7.5% | 11 out of 533 genes, 2.1% | 0.04240143 |
| sexual reproduction | 3 out of 40 genes, 7.5% | 11 out of 533 genes, 2.1% | 0.04240143 |
| single-organism process | 31 out of 40 genes, 77.5% | 341 out of 533 genes, 64.0% | 0.04320349 |
| nuclear-transcribed mRNA catabolic process | 5 out of 40 genes, 12.5% | 27 out of 533 genes, 5.1% | 0.04341699 |
| positive regulation of leukocyte activation | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| regulation of muscle contraction | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| actin filament organization | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| striated muscle tissue development | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| positive regulation of protein complex assembly | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| positive regulation of cell activation | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| positive regulation of cytoskeleton organization | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| muscle cell development | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| striated muscle cell development | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| muscle tissue development | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| regulation of cysteine-type endopeptidase activity | 2 out of 40 genes, 5.0% | 5 out of 533 genes, 0.9% | 0.04754621 |
| viral reproductive process | 6 out of 40 genes, 15.0% | 37 out of 533 genes, 6.9% | 0.04912841 |
| RNA catabolic process | 5 out of 40 genes, 12.5% | 28 out of 533 genes, 5.3% | 0.04996185 |
| mRNA catabolic process | 5 out of 40 genes, 12.5% | 28 out of 533 genes, 5.3% | 0.04996185 |
| cytoskeleton organization | 5 out of 40 genes, 12.5% | 28 out of 533 genes, 5.3% | 0.04996185 |
| cellular component disassembly | 5 out of 40 genes, 12.5% | 28 out of 533 genes, 5.3% | 0.04996185 |
| positive regulation of cell death | 3 out of 40 genes, 7.5% | 12 out of 533 genes, 2.3% | 0.05363294 |
| positive regulation of apoptotic process | 3 out of 40 genes, 7.5% | 12 out of 533 genes, 2.3% | 0.05363294 |
| positive regulation of programmed cell death | 3 out of 40 genes, 7.5% | 12 out of 533 genes, 2.3% | 0.05363294 |
| multi-organism reproductive process | 6 out of 40 genes, 15.0% | 38 out of 533 genes, 7.1% | 0.0551059 |
| cellular nitrogen compound catabolic process | 9 out of 40 genes, 22.5% | 70 out of 533 genes, 13.1% | 0.06363324 |
| heterocycle catabolic process | 9 out of 40 genes, 22.5% | 70 out of 533 genes, 13.1% | 0.06363324 |
| organic cyclic compound catabolic process | 9 out of 40 genes, 22.5% | 70 out of 533 genes, 13.1% | 0.06363324 |
| translational termination | 4 out of 40 genes, 10.0% | 21 out of 533 genes, 3.9% | 0.0640503 |
| viral genome expression | 4 out of 40 genes, 10.0% | 21 out of 533 genes, 3.9% | 0.0640503 |
| viral transcription | 4 out of 40 genes, 10.0% | 21 out of 533 genes, 3.9% | 0.0640503 |
| organ morphogenesis | 3 out of 40 genes, 7.5% | 13 out of 533 genes, 2.4% | 0.06615359 |
| single organism reproductive process | 3 out of 40 genes, 7.5% | 13 out of 533 genes, 2.4% | 0.06615359 |
| regulation of anatomical structure size | 3 out of 40 genes, 7.5% | 13 out of 533 genes, 2.4% | 0.06615359 |
| cellular catabolic process | 12 out of 40 genes, 30.0% | 104 out of 533 genes, 19.5% | 0.06734278 |
| muscle organ development | 2 out of 40 genes, 5.0% | 6 out of 533 genes, 1.1% | 0.06796761 |
| nucleobase metabolic process | 2 out of 40 genes, 5.0% | 6 out of 533 genes, 1.1% | 0.06796761 |
| regulation of endocytosis | 2 out of 40 genes, 5.0% | 6 out of 533 genes, 1.1% | 0.06796761 |
| regulation of proteolysis | 2 out of 40 genes, 5.0% | 6 out of 533 genes, 1.1% | 0.06796761 |
| cell-substrate adhesion | 2 out of 40 genes, 5.0% | 6 out of 533 genes, 1.1% | 0.06796761 |
| regulation of muscle system process | 2 out of 40 genes, 5.0% | 6 out of 533 genes, 1.1% | 0.06796761 |
| protein complex subunit organization | 8 out of 40 genes, 20.0% | 61 out of 533 genes, 11.4% | 0.07242405 |
| protein complex disassembly | 4 out of 40 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.07411052 |
| regulation of kinase activity | 4 out of 40 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.07411052 |
| cellular protein complex disassembly | 4 out of 40 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.07411052 |
| regulation of transferase activity | 4 out of 40 genes, 10.0% | 22 out of 533 genes, 4.1% | 0.07411052 |
| regulation of phosphate metabolic process | 6 out of 40 genes, 15.0% | 42 out of 533 genes, 7.9% | 0.08337275 |
| regulation of phosphorus metabolic process | 6 out of 40 genes, 15.0% | 42 out of 533 genes, 7.9% | 0.08337275 |
| cellular component organization or biogenesis | 18 out of 40 genes, 45.0% | 180 out of 533 genes, 33.8% | 0.08439774 |
| macromolecule catabolic process | 8 out of 40 genes, 20.0% | 63 out of 533 genes, 11.8% | 0.08485985 |
| macromolecular complex disassembly | 4 out of 40 genes, 10.0% | 23 out of 533 genes, 4.3% | 0.08493854 |
| cellular component organization | 17 out of 40 genes, 42.5% | 169 out of 533 genes, 31.7% | 0.09064049 |
| regulation of immune effector process | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| purine nucleoside triphosphate biosynthetic process | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| purine ribonucleoside triphosphate biosynthetic process | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| cellular component assembly involved in morphogenesis | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| regulation of lipid metabolic process | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| platelet activation | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| epithelial cell differentiation | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| striated muscle cell differentiation | 2 out of 40 genes, 5.0% | 7 out of 533 genes, 1.3% | 0.09070627 |
| regulation of cell migration | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| positive regulation of kinase activity | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| regulation of locomotion | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| wound healing | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| regulation of protein complex assembly | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| regulation of system process | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| negative regulation of cellular component organization | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| positive regulation of transferase activity | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| regulation of cell motility | 3 out of 40 genes, 7.5% | 15 out of 533 genes, 2.8% | 0.09478969 |
| cotranslational protein targeting to membrane | 4 out of 40 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.09651178 |
| SRP-dependent cotranslational protein targeting to membrane | 4 out of 40 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.09651178 |
| protein targeting to ER | 4 out of 40 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.09651178 |
| protein localization to endoplasmic reticulum | 4 out of 40 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.09651178 |
| establishment of protein localization to endoplasmic reticulum | 4 out of 40 genes, 10.0% | 24 out of 533 genes, 4.5% | 0.09651178 |
| organic substance catabolic process | 12 out of 40 genes, 30.0% | 111 out of 533 genes, 20.8% | 0.1025678 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 4 out of 40 genes, 10.0% | 25 out of 533 genes, 4.7% | 0.1088029 |
| embryo development | 3 out of 40 genes, 7.5% | 16 out of 533 genes, 3.0% | 0.1107452 |
| cell motility | 3 out of 40 genes, 7.5% | 16 out of 533 genes, 3.0% | 0.1107452 |
| regulation of cellular component movement | 3 out of 40 genes, 7.5% | 16 out of 533 genes, 3.0% | 0.1107452 |
| localization of cell | 3 out of 40 genes, 7.5% | 16 out of 533 genes, 3.0% | 0.1107452 |
| cell differentiation | 7 out of 40 genes, 17.5% | 56 out of 533 genes, 10.5% | 0.1127086 |
| regulation of leukocyte activation | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| RNA localization | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| ribonucleoside triphosphate biosynthetic process | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| nucleobase-containing compound transport | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| purine nucleoside biosynthetic process | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| purine ribonucleoside biosynthetic process | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| nucleic acid transport | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| RNA transport | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| regulation of cell activation | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| nuclear export | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| establishment of RNA localization | 2 out of 40 genes, 5.0% | 8 out of 533 genes, 1.5% | 0.1153182 |
| macromolecule biosynthetic process | 9 out of 40 genes, 22.5% | 79 out of 533 genes, 14.8% | 0.1195765 |
| cellular macromolecule biosynthetic process | 9 out of 40 genes, 22.5% | 79 out of 533 genes, 14.8% | 0.1195765 |
| cellular process | 37 out of 40 genes, 92.5% | 453 out of 533 genes, 85.0% | 0.1201425 |
| single-organism cellular process | 28 out of 40 genes, 70.0% | 320 out of 533 genes, 60.0% | 0.1201593 |
| cellular biosynthetic process | 12 out of 40 genes, 30.0% | 114 out of 533 genes, 21.4% | 0.1207093 |
| protein targeting to membrane | 4 out of 40 genes, 10.0% | 26 out of 533 genes, 4.9% | 0.1217802 |
| protein localization to organelle | 5 out of 40 genes, 12.5% | 36 out of 533 genes, 6.8% | 0.1223908 |
| organelle organization | 9 out of 40 genes, 22.5% | 80 out of 533 genes, 15.0% | 0.1271403 |
| catabolic process | 12 out of 40 genes, 30.0% | 115 out of 533 genes, 21.6% | 0.1271673 |
| regulation of translation | 3 out of 40 genes, 7.5% | 17 out of 533 genes, 3.2% | 0.1276751 |
| apoptotic process | 3 out of 40 genes, 7.5% | 17 out of 533 genes, 3.2% | 0.1276751 |
| programmed cell death | 3 out of 40 genes, 7.5% | 17 out of 533 genes, 3.2% | 0.1276751 |
| regulation of cellular component biogenesis | 3 out of 40 genes, 7.5% | 17 out of 533 genes, 3.2% | 0.1276751 |
| aromatic compound biosynthetic process | 7 out of 40 genes, 17.5% | 58 out of 533 genes, 10.9% | 0.1302795 |
| establishment of protein localization to organelle | 4 out of 40 genes, 10.0% | 27 out of 533 genes, 5.1% | 0.1354086 |
| cellular macromolecule catabolic process | 7 out of 40 genes, 17.5% | 59 out of 533 genes, 11.1% | 0.1395775 |
| cation transport | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| heart development | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| nucleoside triphosphate biosynthetic process | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| regulation of actin filament polymerization | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| cell junction organization | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| muscle cell differentiation | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| tissue morphogenesis | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| regulation of vesicle-mediated transport | 2 out of 40 genes, 5.0% | 9 out of 533 genes, 1.7% | 0.1414102 |
| macromolecular complex subunit organization | 9 out of 40 genes, 22.5% | 82 out of 533 genes, 15.4% | 0.1430607 |
| protein folding | 3 out of 40 genes, 7.5% | 18 out of 533 genes, 3.4% | 0.1454865 |
| cell death | 3 out of 40 genes, 7.5% | 18 out of 533 genes, 3.4% | 0.1454865 |
| death | 3 out of 40 genes, 7.5% | 18 out of 533 genes, 3.4% | 0.1454865 |
| ribosome biogenesis | 3 out of 40 genes, 7.5% | 18 out of 533 genes, 3.4% | 0.1454865 |
| positive regulation of cellular component organization | 3 out of 40 genes, 7.5% | 18 out of 533 genes, 3.4% | 0.1454865 |
| regulation of biological quality | 8 out of 40 genes, 20.0% | 71 out of 533 genes, 13.3% | 0.1468432 |
| organic substance biosynthetic process | 12 out of 40 genes, 30.0% | 118 out of 533 genes, 22.1% | 0.1477652 |
| regulation of multicellular organismal process | 6 out of 40 genes, 15.0% | 49 out of 533 genes, 9.2% | 0.1493443 |
| translational initiation | 4 out of 40 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.1496497 |
| regulation of phosphorylation | 4 out of 40 genes, 10.0% | 28 out of 533 genes, 5.3% | 0.1496497 |
| protein targeting | 5 out of 40 genes, 12.5% | 39 out of 533 genes, 7.3% | 0.1581569 |
| cellular developmental process | 7 out of 40 genes, 17.5% | 61 out of 533 genes, 11.4% | 0.1591608 |
| cytoplasmic transport | 6 out of 40 genes, 15.0% | 50 out of 533 genes, 9.4% | 0.1603665 |
| biosynthetic process | 12 out of 40 genes, 30.0% | 120 out of 533 genes, 22.5% | 0.162503 |
| positive regulation of protein phosphorylation | 3 out of 40 genes, 7.5% | 19 out of 533 genes, 3.6% | 0.1640846 |
| cell development | 4 out of 40 genes, 10.0% | 29 out of 533 genes, 5.4% | 0.1644628 |
| purine nucleotide biosynthetic process | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| regulation of actin polymerization or depolymerization | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| purine ribonucleotide biosynthetic process | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| nucleoside biosynthetic process | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| response to biotic stimulus | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| positive regulation of organelle organization | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| regulation of actin filament length | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| regulation of protein polymerization | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| ribonucleoside biosynthetic process | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| negative regulation of transport | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| purine-containing compound biosynthetic process | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| glycosyl compound biosynthetic process | 2 out of 40 genes, 5.0% | 10 out of 533 genes, 1.9% | 0.168635 |
| organic cyclic compound biosynthetic process | 7 out of 40 genes, 17.5% | 62 out of 533 genes, 11.6% | 0.1694282 |
| anatomical structure development | 8 out of 40 genes, 20.0% | 74 out of 533 genes, 13.9% | 0.1749227 |
| system process | 3 out of 40 genes, 7.5% | 20 out of 533 genes, 3.8% | 0.1833746 |
| positive regulation of phosphorylation | 3 out of 40 genes, 7.5% | 20 out of 533 genes, 3.8% | 0.1833746 |
| regulation of protein kinase activity | 3 out of 40 genes, 7.5% | 20 out of 533 genes, 3.8% | 0.1833746 |
| organonitrogen compound biosynthetic process | 3 out of 40 genes, 7.5% | 20 out of 533 genes, 3.8% | 0.1833746 |
| response to stress | 8 out of 40 genes, 20.0% | 76 out of 533 genes, 14.3% | 0.194978 |
| organ development | 4 out of 40 genes, 10.0% | 31 out of 533 genes, 5.8% | 0.1956315 |
| regulation of cytokine production | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| positive regulation of immune system process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| rRNA processing | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| regulation of nucleoside metabolic process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| ribonucleotide biosynthetic process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| rRNA metabolic process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| regulation of nucleotide catabolic process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| regulation of actin cytoskeleton organization | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| regulation of actin filament-based process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| regulation of purine nucleotide catabolic process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| ribose phosphate biosynthetic process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| positive regulation of multicellular organismal process | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| epithelium development | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| muscle structure development | 2 out of 40 genes, 5.0% | 11 out of 533 genes, 2.1% | 0.1966869 |
| response to abiotic stimulus | 3 out of 40 genes, 7.5% | 21 out of 533 genes, 3.9% | 0.2032619 |
| nucleobase-containing compound catabolic process | 7 out of 40 genes, 17.5% | 66 out of 533 genes, 12.4% | 0.2134178 |
| nucleobase-containing compound biosynthetic process | 6 out of 40 genes, 15.0% | 55 out of 533 genes, 10.3% | 0.2205914 |
| positive regulation of phosphorus metabolic process | 3 out of 40 genes, 7.5% | 22 out of 533 genes, 4.1% | 0.2236543 |
| positive regulation of phosphate metabolic process | 3 out of 40 genes, 7.5% | 22 out of 533 genes, 4.1% | 0.2236543 |
| aromatic compound catabolic process | 7 out of 40 genes, 17.5% | 67 out of 533 genes, 12.6% | 0.2250833 |
| blood coagulation | 2 out of 40 genes, 5.0% | 12 out of 533 genes, 2.3% | 0.2252977 |
| hemostasis | 2 out of 40 genes, 5.0% | 12 out of 533 genes, 2.3% | 0.2252977 |
| regulation of defense response | 2 out of 40 genes, 5.0% | 12 out of 533 genes, 2.3% | 0.2252977 |
| regulation of cellular component size | 2 out of 40 genes, 5.0% | 12 out of 533 genes, 2.3% | 0.2252977 |
| coagulation | 2 out of 40 genes, 5.0% | 12 out of 533 genes, 2.3% | 0.2252977 |
| positive regulation of developmental process | 2 out of 40 genes, 5.0% | 12 out of 533 genes, 2.3% | 0.2252977 |
| response to wounding | 3 out of 40 genes, 7.5% | 23 out of 533 genes, 4.3% | 0.2444616 |
| multicellular organismal process | 9 out of 40 genes, 22.5% | 93 out of 533 genes, 17.4% | 0.2478771 |
| regulation of nucleotide metabolic process | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| ion transport | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| nucleocytoplasmic transport | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| regulation of cellular catabolic process | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| positive regulation of protein kinase activity | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| nuclear transport | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| nitrogen compound transport | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| regulation of purine nucleotide metabolic process | 2 out of 40 genes, 5.0% | 13 out of 533 genes, 2.4% | 0.254233 |
| gene expression | 10 out of 40 genes, 25.0% | 107 out of 533 genes, 20.1% | 0.2659576 |
| transport | 12 out of 40 genes, 30.0% | 132 out of 533 genes, 24.8% | 0.2663868 |
| heterocycle biosynthetic process | 6 out of 40 genes, 15.0% | 59 out of 533 genes, 11.1% | 0.2738297 |
| cellular nitrogen compound biosynthetic process | 6 out of 40 genes, 15.0% | 59 out of 533 genes, 11.1% | 0.2738297 |
| establishment of localization | 12 out of 40 genes, 30.0% | 133 out of 533 genes, 25.0% | 0.2760922 |
| regulation of body fluid levels | 2 out of 40 genes, 5.0% | 14 out of 533 genes, 2.6% | 0.2832889 |
| cardiovascular system development | 2 out of 40 genes, 5.0% | 14 out of 533 genes, 2.6% | 0.2832889 |
| circulatory system development | 2 out of 40 genes, 5.0% | 14 out of 533 genes, 2.6% | 0.2832889 |
| regulation of protein phosphorylation | 3 out of 40 genes, 7.5% | 25 out of 533 genes, 4.7% | 0.2869784 |
| translational elongation | 3 out of 40 genes, 7.5% | 25 out of 533 genes, 4.7% | 0.2869784 |
| ribonucleoprotein complex biogenesis | 3 out of 40 genes, 7.5% | 25 out of 533 genes, 4.7% | 0.2869784 |
| cellular component morphogenesis | 3 out of 40 genes, 7.5% | 25 out of 533 genes, 4.7% | 0.2869784 |
| negative regulation of molecular function | 3 out of 40 genes, 7.5% | 25 out of 533 genes, 4.7% | 0.2869784 |
| RNA biosynthetic process | 4 out of 40 genes, 10.0% | 37 out of 533 genes, 6.9% | 0.2981946 |
| localization | 13 out of 40 genes, 32.5% | 148 out of 533 genes, 27.8% | 0.2987771 |
| regulation of protein metabolic process | 6 out of 40 genes, 15.0% | 61 out of 533 genes, 11.4% | 0.3016966 |
| M phase | 2 out of 40 genes, 5.0% | 15 out of 533 genes, 2.8% | 0.3122887 |
| cell migration | 2 out of 40 genes, 5.0% | 15 out of 533 genes, 2.8% | 0.3122887 |
| ncRNA processing | 2 out of 40 genes, 5.0% | 15 out of 533 genes, 2.8% | 0.3122887 |
| posttranscriptional regulation of gene expression | 3 out of 40 genes, 7.5% | 27 out of 533 genes, 5.1% | 0.3301656 |
| regulation of response to stress | 3 out of 40 genes, 7.5% | 27 out of 533 genes, 5.1% | 0.3301656 |
| single-multicellular organism process | 8 out of 40 genes, 20.0% | 88 out of 533 genes, 16.5% | 0.3329785 |
| intracellular protein transport | 5 out of 40 genes, 12.5% | 51 out of 533 genes, 9.6% | 0.333316 |
| regulation of cellular protein metabolic process | 5 out of 40 genes, 12.5% | 51 out of 533 genes, 9.6% | 0.333316 |
| system development | 5 out of 40 genes, 12.5% | 51 out of 533 genes, 9.6% | 0.333316 |
| nucleotide biosynthetic process | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| virus-host interaction | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| regulation of anatomical structure morphogenesis | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| symbiosis, encompassing mutualism through parasitism | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| interspecies interaction between organisms | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| regulation of cytoskeleton organization | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| interaction with host | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| nucleoside phosphate biosynthetic process | 2 out of 40 genes, 5.0% | 16 out of 533 genes, 3.0% | 0.3410807 |
| regulation of metabolic process | 14 out of 40 genes, 35.0% | 166 out of 533 genes, 31.1% | 0.3497804 |
| positive regulation of protein modification process | 3 out of 40 genes, 7.5% | 28 out of 533 genes, 5.3% | 0.3518276 |
| locomotion | 3 out of 40 genes, 7.5% | 28 out of 533 genes, 5.3% | 0.3518276 |
| negative regulation of response to stimulus | 3 out of 40 genes, 7.5% | 28 out of 533 genes, 5.3% | 0.3518276 |
| organonitrogen compound catabolic process | 4 out of 40 genes, 10.0% | 40 out of 533 genes, 7.5% | 0.3523139 |
| single-organism developmental process | 6 out of 40 genes, 15.0% | 65 out of 533 genes, 12.2% | 0.3590804 |
| chemical homeostasis | 2 out of 40 genes, 5.0% | 17 out of 533 genes, 3.2% | 0.3695347 |
| organophosphate biosynthetic process | 2 out of 40 genes, 5.0% | 17 out of 533 genes, 3.2% | 0.3695347 |
| cellular protein metabolic process | 12 out of 40 genes, 30.0% | 143 out of 533 genes, 26.8% | 0.3793671 |
| cellular aromatic compound metabolic process | 14 out of 40 genes, 35.0% | 169 out of 533 genes, 31.7% | 0.3801428 |
| homeostatic process | 3 out of 40 genes, 7.5% | 30 out of 533 genes, 5.6% | 0.3949623 |
| nucleobase-containing small molecule metabolic process | 5 out of 40 genes, 12.5% | 55 out of 533 genes, 10.3% | 0.397396 |
| carbohydrate derivative biosynthetic process | 2 out of 40 genes, 5.0% | 18 out of 533 genes, 3.4% | 0.3975408 |
| positive regulation of cellular process | 9 out of 40 genes, 22.5% | 106 out of 533 genes, 19.9% | 0.3982971 |
| protein metabolic process | 13 out of 40 genes, 32.5% | 158 out of 533 genes, 29.6% | 0.4010064 |
| developmental process | 8 out of 40 genes, 20.0% | 94 out of 533 genes, 17.6% | 0.4089052 |
| organonitrogen compound metabolic process | 6 out of 40 genes, 15.0% | 69 out of 533 genes, 12.9% | 0.4175442 |
| regulation of catabolic process | 2 out of 40 genes, 5.0% | 19 out of 533 genes, 3.6% | 0.4250062 |
| cellular response to oxygen-containing compound | 2 out of 40 genes, 5.0% | 19 out of 533 genes, 3.6% | 0.4250062 |
| biological regulation | 22 out of 40 genes, 55.0% | 279 out of 533 genes, 52.3% | 0.4275978 |
| protein catabolic process | 3 out of 40 genes, 7.5% | 32 out of 533 genes, 6.0% | 0.4374663 |
| positive regulation of cellular protein metabolic process | 3 out of 40 genes, 7.5% | 32 out of 533 genes, 6.0% | 0.4374663 |
| multicellular organismal development | 6 out of 40 genes, 15.0% | 71 out of 533 genes, 13.3% | 0.4467781 |
| organic substance transport | 7 out of 40 genes, 17.5% | 84 out of 533 genes, 15.8% | 0.4473129 |
| cellular membrane organization | 2 out of 40 genes, 5.0% | 20 out of 533 genes, 3.8% | 0.4518542 |
| anatomical structure formation involved in morphogenesis | 2 out of 40 genes, 5.0% | 20 out of 533 genes, 3.8% | 0.4518542 |
| membrane organization | 2 out of 40 genes, 5.0% | 20 out of 533 genes, 3.8% | 0.4518542 |
| organic cyclic compound metabolic process | 14 out of 40 genes, 35.0% | 176 out of 533 genes, 33.0% | 0.4527859 |
| regulation of primary metabolic process | 12 out of 40 genes, 30.0% | 150 out of 533 genes, 28.1% | 0.4556548 |
| cellular macromolecule metabolic process | 17 out of 40 genes, 42.5% | 216 out of 533 genes, 40.5% | 0.4578334 |
| protein transport | 6 out of 40 genes, 15.0% | 72 out of 533 genes, 13.5% | 0.4613295 |
| response to chemical stimulus | 6 out of 40 genes, 15.0% | 72 out of 533 genes, 13.5% | 0.4613295 |
| nucleobase-containing compound metabolic process | 13 out of 40 genes, 32.5% | 165 out of 533 genes, 31.0% | 0.4756737 |
| establishment of protein localization | 6 out of 40 genes, 15.0% | 73 out of 533 genes, 13.7% | 0.4758135 |
| cellular protein localization | 5 out of 40 genes, 12.5% | 60 out of 533 genes, 11.3% | 0.4771458 |
| cellular macromolecule localization | 5 out of 40 genes, 12.5% | 60 out of 533 genes, 11.3% | 0.4771458 |
| ncRNA metabolic process | 2 out of 40 genes, 5.0% | 21 out of 533 genes, 3.9% | 0.4780218 |
| negative regulation of catalytic activity | 2 out of 40 genes, 5.0% | 21 out of 533 genes, 3.9% | 0.4780218 |
| nucleic acid metabolic process | 9 out of 40 genes, 22.5% | 114 out of 533 genes, 21.4% | 0.4956363 |
| cellular response to chemical stimulus | 4 out of 40 genes, 10.0% | 48 out of 533 genes, 9.0% | 0.4957479 |
| regulation of cell death | 3 out of 40 genes, 7.5% | 35 out of 533 genes, 6.6% | 0.4992083 |
| regulation of protein modification process | 3 out of 40 genes, 7.5% | 35 out of 533 genes, 6.6% | 0.4992083 |
| regulation of apoptotic process | 3 out of 40 genes, 7.5% | 35 out of 533 genes, 6.6% | 0.4992083 |
| regulation of programmed cell death | 3 out of 40 genes, 7.5% | 35 out of 533 genes, 6.6% | 0.4992083 |
| RNA metabolic process | 7 out of 40 genes, 17.5% | 88 out of 533 genes, 16.5% | 0.5012272 |
| regulation of organelle organization | 2 out of 40 genes, 5.0% | 22 out of 533 genes, 4.1% | 0.5034585 |
| nitrogen compound metabolic process | 14 out of 40 genes, 35.0% | 181 out of 533 genes, 34.0% | 0.5051663 |
| cellular component biogenesis | 7 out of 40 genes, 17.5% | 89 out of 533 genes, 16.7% | 0.5145248 |
| positive regulation of protein metabolic process | 3 out of 40 genes, 7.5% | 36 out of 533 genes, 6.8% | 0.5190975 |
| positive regulation of biological process | 9 out of 40 genes, 22.5% | 116 out of 533 genes, 21.8% | 0.5196867 |
| cell cycle phase | 2 out of 40 genes, 5.0% | 23 out of 533 genes, 4.3% | 0.5281249 |
| regulation of multicellular organismal development | 2 out of 40 genes, 5.0% | 23 out of 533 genes, 4.3% | 0.5281249 |
| heterocycle metabolic process | 13 out of 40 genes, 32.5% | 170 out of 533 genes, 31.9% | 0.5289379 |
| positive regulation of response to stimulus | 3 out of 40 genes, 7.5% | 37 out of 533 genes, 6.9% | 0.538589 |
| regulation of developmental process | 3 out of 40 genes, 7.5% | 37 out of 533 genes, 6.9% | 0.538589 |
| cellular localization | 7 out of 40 genes, 17.5% | 91 out of 533 genes, 17.1% | 0.5408123 |
| intracellular transport | 6 out of 40 genes, 15.0% | 78 out of 533 genes, 14.6% | 0.5466562 |
| mitotic cell cycle | 2 out of 40 genes, 5.0% | 24 out of 533 genes, 4.5% | 0.551991 |
| response to external stimulus | 2 out of 40 genes, 5.0% | 24 out of 533 genes, 4.5% | 0.551991 |
| negative regulation of signal transduction | 2 out of 40 genes, 5.0% | 24 out of 533 genes, 4.5% | 0.551991 |
| immune system process | 3 out of 40 genes, 7.5% | 38 out of 533 genes, 7.1% | 0.5576571 |
| regulation of localization | 4 out of 40 genes, 10.0% | 52 out of 533 genes, 9.8% | 0.5631867 |
| mRNA metabolic process | 5 out of 40 genes, 12.5% | 66 out of 533 genes, 12.4% | 0.5686231 |
| cellular nitrogen compound metabolic process | 13 out of 40 genes, 32.5% | 174 out of 533 genes, 32.6% | 0.5708163 |
| regulation of cell cycle | 2 out of 40 genes, 5.0% | 25 out of 533 genes, 4.7% | 0.5750356 |
| purine nucleoside triphosphate metabolic process | 3 out of 40 genes, 7.5% | 39 out of 533 genes, 7.3% | 0.5762801 |
| purine ribonucleoside triphosphate metabolic process | 3 out of 40 genes, 7.5% | 39 out of 533 genes, 7.3% | 0.5762801 |
| anatomical structure morphogenesis | 3 out of 40 genes, 7.5% | 39 out of 533 genes, 7.3% | 0.5762801 |
| cellular response to organic substance | 3 out of 40 genes, 7.5% | 39 out of 533 genes, 7.3% | 0.5762801 |
| regulation of cellular metabolic process | 11 out of 40 genes, 27.5% | 148 out of 533 genes, 27.8% | 0.5792325 |
| macromolecule localization | 7 out of 40 genes, 17.5% | 94 out of 533 genes, 17.6% | 0.5793002 |
| response to organic substance | 4 out of 40 genes, 10.0% | 53 out of 533 genes, 9.9% | 0.5793434 |
| response to stimulus | 13 out of 40 genes, 32.5% | 175 out of 533 genes, 32.8% | 0.581128 |
| macromolecule metabolic process | 17 out of 40 genes, 42.5% | 229 out of 533 genes, 43.0% | 0.5874422 |
| ribonucleoside triphosphate metabolic process | 3 out of 40 genes, 7.5% | 40 out of 533 genes, 7.5% | 0.5944396 |
| purine nucleoside metabolic process | 3 out of 40 genes, 7.5% | 40 out of 533 genes, 7.5% | 0.5944396 |
| purine ribonucleoside metabolic process | 3 out of 40 genes, 7.5% | 40 out of 533 genes, 7.5% | 0.5944396 |
| regulation of immune system process | 2 out of 40 genes, 5.0% | 26 out of 533 genes, 4.9% | 0.5972447 |
| negative regulation of cell communication | 2 out of 40 genes, 5.0% | 26 out of 533 genes, 4.9% | 0.5972447 |
| negative regulation of signaling | 2 out of 40 genes, 5.0% | 26 out of 533 genes, 4.9% | 0.5972447 |
| establishment of localization in cell | 6 out of 40 genes, 15.0% | 82 out of 533 genes, 15.4% | 0.6005892 |
| cellular metabolic process | 22 out of 40 genes, 55.0% | 297 out of 533 genes, 55.7% | 0.6047746 |
| nucleoside triphosphate metabolic process | 3 out of 40 genes, 7.5% | 41 out of 533 genes, 7.7% | 0.6121201 |
| cell projection organization | 2 out of 40 genes, 5.0% | 27 out of 533 genes, 5.1% | 0.6186111 |
| chromosome organization | 2 out of 40 genes, 5.0% | 27 out of 533 genes, 5.1% | 0.6186111 |
| response to oxygen-containing compound | 2 out of 40 genes, 5.0% | 27 out of 533 genes, 5.1% | 0.6186111 |
| protein localization | 6 out of 40 genes, 15.0% | 84 out of 533 genes, 15.8% | 0.6263825 |
| ribonucleoside metabolic process | 3 out of 40 genes, 7.5% | 42 out of 533 genes, 7.9% | 0.6293096 |
| regulation of response to stimulus | 5 out of 40 genes, 12.5% | 71 out of 533 genes, 13.3% | 0.6388561 |
| signal transduction | 7 out of 40 genes, 17.5% | 99 out of 533 genes, 18.6% | 0.640262 |
| negative regulation of cellular process | 7 out of 40 genes, 17.5% | 99 out of 533 genes, 18.6% | 0.640262 |
| purine nucleotide metabolic process | 3 out of 40 genes, 7.5% | 43 out of 533 genes, 8.1% | 0.6459984 |
| nucleoside metabolic process | 3 out of 40 genes, 7.5% | 43 out of 533 genes, 8.1% | 0.6459984 |
| purine ribonucleotide metabolic process | 3 out of 40 genes, 7.5% | 43 out of 533 genes, 8.1% | 0.6459984 |
| purine-containing compound metabolic process | 3 out of 40 genes, 7.5% | 43 out of 533 genes, 8.1% | 0.6459984 |
| glycosyl compound metabolic process | 3 out of 40 genes, 7.5% | 43 out of 533 genes, 8.1% | 0.6459984 |
| proteolysis involved in cellular protein catabolic process | 2 out of 40 genes, 5.0% | 29 out of 533 genes, 5.4% | 0.6588133 |
| ribonucleotide metabolic process | 3 out of 40 genes, 7.5% | 44 out of 533 genes, 8.3% | 0.6621797 |
| ribose phosphate metabolic process | 3 out of 40 genes, 7.5% | 44 out of 533 genes, 8.3% | 0.6621797 |
| primary metabolic process | 22 out of 40 genes, 55.0% | 304 out of 533 genes, 57.0% | 0.6704822 |
| cellular macromolecular complex assembly | 2 out of 40 genes, 5.0% | 30 out of 533 genes, 5.6% | 0.6776598 |
| cellular protein catabolic process | 2 out of 40 genes, 5.0% | 30 out of 533 genes, 5.6% | 0.6776598 |
| negative regulation of nucleobase-containing compound metabolic process | 2 out of 40 genes, 5.0% | 30 out of 533 genes, 5.6% | 0.6776598 |
| GTP metabolic process | 2 out of 40 genes, 5.0% | 30 out of 533 genes, 5.6% | 0.6776598 |
| negative regulation of nitrogen compound metabolic process | 2 out of 40 genes, 5.0% | 30 out of 533 genes, 5.6% | 0.6776598 |
| guanosine-containing compound metabolic process | 2 out of 40 genes, 5.0% | 30 out of 533 genes, 5.6% | 0.6776598 |
| cellular component assembly | 5 out of 40 genes, 12.5% | 74 out of 533 genes, 13.9% | 0.6777375 |
| signaling | 7 out of 40 genes, 17.5% | 103 out of 533 genes, 19.3% | 0.6855901 |
| single organism signaling | 7 out of 40 genes, 17.5% | 103 out of 533 genes, 19.3% | 0.6855901 |
| positive regulation of metabolic process | 5 out of 40 genes, 12.5% | 75 out of 533 genes, 14.1% | 0.6901107 |
| negative regulation of cellular metabolic process | 3 out of 40 genes, 7.5% | 46 out of 533 genes, 8.6% | 0.6930035 |
| regulation of cellular component organization | 3 out of 40 genes, 7.5% | 46 out of 533 genes, 8.6% | 0.6930035 |
| cellular response to stimulus | 9 out of 40 genes, 22.5% | 133 out of 533 genes, 25.0% | 0.7063947 |
| positive regulation of signal transduction | 2 out of 40 genes, 5.0% | 32 out of 533 genes, 6.0% | 0.7128978 |
| positive regulation of cell communication | 2 out of 40 genes, 5.0% | 32 out of 533 genes, 6.0% | 0.7128978 |
| positive regulation of signaling | 2 out of 40 genes, 5.0% | 32 out of 533 genes, 6.0% | 0.7128978 |
| cell communication | 7 out of 40 genes, 17.5% | 107 out of 533 genes, 20.1% | 0.7274672 |
| negative regulation of biological process | 7 out of 40 genes, 17.5% | 107 out of 533 genes, 20.1% | 0.7274672 |
| purine nucleoside catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| nucleoside triphosphate catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| purine nucleoside triphosphate catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| nucleoside catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| ribonucleoside triphosphate catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| purine ribonucleoside triphosphate catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| cell cycle process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| ribonucleoside catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| purine ribonucleoside catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| glycosyl compound catabolic process | 2 out of 40 genes, 5.0% | 33 out of 533 genes, 6.2% | 0.7293198 |
| organic substance metabolic process | 22 out of 40 genes, 55.0% | 311 out of 533 genes, 58.3% | 0.7316343 |
| RNA processing | 3 out of 40 genes, 7.5% | 49 out of 533 genes, 9.2% | 0.7353856 |
| purine nucleotide catabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| DNA metabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| purine ribonucleotide catabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| nucleotide catabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| ribonucleotide catabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| organophosphate catabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| purine-containing compound catabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| nucleoside phosphate catabolic process | 2 out of 40 genes, 5.0% | 34 out of 533 genes, 6.4% | 0.7449679 |
| small molecule metabolic process | 6 out of 40 genes, 15.0% | 95 out of 533 genes, 17.8% | 0.751219 |
| carbohydrate derivative catabolic process | 2 out of 40 genes, 5.0% | 35 out of 533 genes, 6.6% | 0.7598624 |
| nucleoside phosphate metabolic process | 3 out of 40 genes, 7.5% | 51 out of 533 genes, 9.6% | 0.7611062 |
| nucleotide metabolic process | 3 out of 40 genes, 7.5% | 51 out of 533 genes, 9.6% | 0.7611062 |
| carbohydrate derivative metabolic process | 3 out of 40 genes, 7.5% | 51 out of 533 genes, 9.6% | 0.7611062 |
| negative regulation of macromolecule metabolic process | 3 out of 40 genes, 7.5% | 52 out of 533 genes, 9.8% | 0.7732237 |
| nervous system development | 2 out of 40 genes, 5.0% | 36 out of 533 genes, 6.8% | 0.774025 |
| regulation of transport | 2 out of 40 genes, 5.0% | 36 out of 533 genes, 6.8% | 0.774025 |
| single-organism metabolic process | 7 out of 40 genes, 17.5% | 113 out of 533 genes, 21.2% | 0.7833821 |
| negative regulation of metabolic process | 3 out of 40 genes, 7.5% | 53 out of 533 genes, 9.9% | 0.7848565 |
| organophosphate metabolic process | 3 out of 40 genes, 7.5% | 53 out of 533 genes, 9.9% | 0.7848565 |
| positive regulation of cellular metabolic process | 4 out of 40 genes, 10.0% | 69 out of 533 genes, 12.9% | 0.7893559 |
| regulation of biological process | 18 out of 40 genes, 45.0% | 267 out of 533 genes, 50.1% | 0.7978233 |
| positive regulation of macromolecule metabolic process | 4 out of 40 genes, 10.0% | 70 out of 533 genes, 13.1% | 0.7992969 |
| metabolic process | 22 out of 40 genes, 55.0% | 321 out of 533 genes, 60.2% | 0.808424 |
| regulation of macromolecule metabolic process | 9 out of 40 genes, 22.5% | 146 out of 533 genes, 27.4% | 0.8162766 |
| cell surface receptor signaling pathway | 3 out of 40 genes, 7.5% | 56 out of 533 genes, 10.5% | 0.8169409 |
| cell cycle | 2 out of 40 genes, 5.0% | 40 out of 533 genes, 7.5% | 0.8238217 |
| cellular response to stress | 2 out of 40 genes, 5.0% | 40 out of 533 genes, 7.5% | 0.8238217 |
| regulation of signal transduction | 3 out of 40 genes, 7.5% | 58 out of 533 genes, 10.9% | 0.8360915 |
| proteolysis | 2 out of 40 genes, 5.0% | 42 out of 533 genes, 7.9% | 0.8449467 |
| regulation of biosynthetic process | 6 out of 40 genes, 15.0% | 108 out of 533 genes, 20.3% | 0.8582522 |
| regulation of nucleobase-containing compound metabolic process | 6 out of 40 genes, 15.0% | 111 out of 533 genes, 20.8% | 0.8769928 |
| regulation of cell communication | 3 out of 40 genes, 7.5% | 66 out of 533 genes, 12.4% | 0.8968622 |
| regulation of cellular macromolecule biosynthetic process | 5 out of 40 genes, 12.5% | 99 out of 533 genes, 18.6% | 0.8972039 |
| regulation of nitrogen compound metabolic process | 6 out of 40 genes, 15.0% | 115 out of 533 genes, 21.6% | 0.8988708 |
| regulation of signaling | 3 out of 40 genes, 7.5% | 67 out of 533 genes, 12.6% | 0.9028854 |
| regulation of gene expression | 6 out of 40 genes, 15.0% | 116 out of 533 genes, 21.8% | 0.9038178 |
| macromolecular complex assembly | 2 out of 40 genes, 5.0% | 50 out of 533 genes, 9.4% | 0.9087799 |
| regulation of macromolecule biosynthetic process | 5 out of 40 genes, 12.5% | 103 out of 533 genes, 19.3% | 0.9168678 |
| regulation of cellular process | 15 out of 40 genes, 37.5% | 249 out of 533 genes, 46.7% | 0.9169176 |
| regulation of cellular biosynthetic process | 5 out of 40 genes, 12.5% | 105 out of 533 genes, 19.7% | 0.9254529 |
| phosphorus metabolic process | 3 out of 40 genes, 7.5% | 75 out of 533 genes, 14.1% | 0.9409977 |
| phosphate-containing compound metabolic process | 3 out of 40 genes, 7.5% | 75 out of 533 genes, 14.1% | 0.9409977 |
| regulation of RNA metabolic process | 3 out of 40 genes, 7.5% | 92 out of 533 genes, 17.3% | 0.9813308 |
| regulation of transcription, DNA-dependent | 2 out of 40 genes, 5.0% | 82 out of 533 genes, 15.4% | 0.9915248 |
| regulation of RNA biosynthetic process | 2 out of 40 genes, 5.0% | 84 out of 533 genes, 15.8% | 0.9927793 |
| Gene Ontology term | Genes annotated to the term |
|---|
| actin-myosin filament sliding | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| actin-mediated cell contraction | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000012216, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000014372 |
| positive regulation of hydrolase activity | ENSAPLP00000004358, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372 |
| muscle system process | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| muscle contraction | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| activation of cysteine-type endopeptidase activity involved in apoptotic process | ENSAPLP00000004358, ENSAPLP00000014372 |
| regulation of blood pressure | ENSAPLP00000003219, ENSAPLP00000002381 |
| gas transport | ENSAPLP00000011711, ENSAPLP00000015662 |
| ruffle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| negative regulation of endocytosis | ENSAPLP00000003050, ENSAPLP00000002414 |
| activation of cysteine-type endopeptidase activity | ENSAPLP00000004358, ENSAPLP00000014372 |
| actin filament-based movement | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| positive regulation of catalytic activity | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372 |
| actin filament-based process | ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000002381 |
| positive regulation of molecular function | ENSAPLP00000013416, ENSAPLP00000002711, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000014372 |
| regulation of catalytic activity | ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000014372 |
| reproduction | ENSAPLP00000013416, ENSAPLP00000004776, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000002414, ENSAPLP00000009200, ENSAPLP00000011900, ENSAPLP00000011529, ENSAPLP00000014372 |
| pyrimidine nucleobase metabolic process | ENSAPLP00000007333, ENSAPLP00000009975 |
| pyrimidine nucleobase catabolic process | ENSAPLP00000007333, ENSAPLP00000009975 |
| response to unfolded protein | ENSAPLP00000004358, ENSAPLP00000002711 |
| regulation of heart contraction | ENSAPLP00000003219, ENSAPLP00000012915 |
| fertilization | ENSAPLP00000011900, ENSAPLP00000011529 |
| muscle filament sliding | ENSAPLP00000003219, ENSAPLP00000015089 |
| positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | ENSAPLP00000004358, ENSAPLP00000014372 |
| nucleobase catabolic process | ENSAPLP00000007333, ENSAPLP00000009975 |
| muscle organ morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue development | ENSAPLP00000003219, ENSAPLP00000002381 |
| cardiac muscle tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| pyrimidine-containing compound catabolic process | ENSAPLP00000007333, ENSAPLP00000009975 |
| positive regulation of cysteine-type endopeptidase activity | ENSAPLP00000004358, ENSAPLP00000014372 |
| pyrimidine-containing compound metabolic process | ENSAPLP00000007333, ENSAPLP00000002225, ENSAPLP00000009975 |
| regulation of molecular function | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000003219, ENSAPLP00000014372 |
| cell adhesion | ENSAPLP00000003050, ENSAPLP00000013787, ENSAPLP00000013159, ENSAPLP00000015617, ENSAPLP00000003689, ENSAPLP00000000439 |
| biological adhesion | ENSAPLP00000003050, ENSAPLP00000013787, ENSAPLP00000013159, ENSAPLP00000015617, ENSAPLP00000003689, ENSAPLP00000000439 |
| actin cytoskeleton organization | ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000014548, ENSAPLP00000002381 |
| viral infectious cycle | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| reproductive process | ENSAPLP00000013416, ENSAPLP00000004776, ENSAPLP00000007620, ENSAPLP00000002414, ENSAPLP00000009200, ENSAPLP00000011900, ENSAPLP00000011529, ENSAPLP00000014372 |
| cellular process involved in reproduction | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| translation | ENSAPLP00000014148, ENSAPLP00000004776, ENSAPLP00000011518, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000014372, ENSAPLP00000016333 |
| viral reproduction | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| multi-organism cellular process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of response to biotic stimulus | ENSAPLP00000004358, ENSAPLP00000003050 |
| heart morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system process | ENSAPLP00000003219, ENSAPLP00000002381 |
| heart process | ENSAPLP00000003219, ENSAPLP00000002381 |
| RNA export from nucleus | ENSAPLP00000013416, ENSAPLP00000015617 |
| blood circulation | ENSAPLP00000003219, ENSAPLP00000002381 |
| positive regulation of endopeptidase activity | ENSAPLP00000004358, ENSAPLP00000014372 |
| positive regulation of peptidase activity | ENSAPLP00000004358, ENSAPLP00000014372 |
| myofibril assembly | ENSAPLP00000003219, ENSAPLP00000002381 |
| actomyosin structure organization | ENSAPLP00000003219, ENSAPLP00000002381 |
| response to topologically incorrect protein | ENSAPLP00000004358, ENSAPLP00000002711 |
| ribosomal small subunit biogenesis | ENSAPLP00000015617, ENSAPLP00000015662 |
| heart contraction | ENSAPLP00000003219, ENSAPLP00000002381 |
| tissue development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000002381 |
| regulation of peptidase activity | ENSAPLP00000004358, ENSAPLP00000012216, ENSAPLP00000014372 |
| regulation of endopeptidase activity | ENSAPLP00000004358, ENSAPLP00000012216, ENSAPLP00000014372 |
| single-organism transport | ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372 |
| multi-organism process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372, ENSAPLP00000002381 |
| cellular component movement | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000008674, ENSAPLP00000015089, ENSAPLP00000002381 |
| cell activation | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003867 |
| sexual reproduction | ENSAPLP00000013416, ENSAPLP00000011900, ENSAPLP00000011529 |
| single-organism process | ENSAPLP00000013787, ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000004776, ENSAPLP00000003689, ENSAPLP00000000439, ENSAPLP00000015662, ENSAPLP00000004358, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000002414, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000011000, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000015089, ENSAPLP00000011711, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004030, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000011900, ENSAPLP00000003219, ENSAPLP00000007620 |
| nuclear-transcribed mRNA catabolic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000014372 |
| positive regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| regulation of muscle contraction | ENSAPLP00000003219, ENSAPLP00000015089 |
| actin filament organization | ENSAPLP00000014548, ENSAPLP00000002381 |
| striated muscle tissue development | ENSAPLP00000003219, ENSAPLP00000002381 |
| positive regulation of protein complex assembly | ENSAPLP00000003050, ENSAPLP00000002414 |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process | ENSAPLP00000004358, ENSAPLP00000014372 |
| positive regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| positive regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| muscle cell development | ENSAPLP00000003219, ENSAPLP00000002381 |
| striated muscle cell development | ENSAPLP00000003219, ENSAPLP00000002381 |
| muscle tissue development | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of cysteine-type endopeptidase activity | ENSAPLP00000004358, ENSAPLP00000014372 |
| viral reproductive process | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| RNA catabolic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000014372 |
| mRNA catabolic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000014372 |
| cytoskeleton organization | ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000007333, ENSAPLP00000014548, ENSAPLP00000002381 |
| cellular component disassembly | ENSAPLP00000000447, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| positive regulation of cell death | ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000014372 |
| positive regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000014372 |
| positive regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000014372 |
| multi-organism reproductive process | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular nitrogen compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| heterocycle catabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| organic cyclic compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| translational termination | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| viral genome expression | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| viral transcription | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| organ morphogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| single organism reproductive process | ENSAPLP00000013416, ENSAPLP00000011900, ENSAPLP00000011529 |
| regulation of anatomical structure size | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular catabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| muscle organ development | ENSAPLP00000003219, ENSAPLP00000002381 |
| nucleobase metabolic process | ENSAPLP00000007333, ENSAPLP00000009975 |
| regulation of endocytosis | ENSAPLP00000003050, ENSAPLP00000002414 |
| regulation of proteolysis | ENSAPLP00000012216, ENSAPLP00000002414 |
| cell-substrate adhesion | ENSAPLP00000003050, ENSAPLP00000013787 |
| regulation of muscle system process | ENSAPLP00000003219, ENSAPLP00000015089 |
| protein complex subunit organization | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000003867, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000014372, ENSAPLP00000002381 |
| protein complex disassembly | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| cellular protein complex disassembly | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| regulation of phosphate metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014548 |
| regulation of phosphorus metabolic process | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014548 |
| cellular component organization or biogenesis | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000004776, ENSAPLP00000003689, ENSAPLP00000015662, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000011000, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000000447 |
| macromolecule catabolic process | ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000014372 |
| macromolecular complex disassembly | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular component organization | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000004776, ENSAPLP00000003689, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000011000, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000007620, ENSAPLP00000003219, ENSAPLP00000000447 |
| regulation of immune effector process | ENSAPLP00000004358, ENSAPLP00000003050 |
| purine nucleoside triphosphate biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| purine ribonucleoside triphosphate biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| cellular component assembly involved in morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of lipid metabolic process | ENSAPLP00000003050, ENSAPLP00000011529 |
| platelet activation | ENSAPLP00000003050, ENSAPLP00000003867 |
| epithelial cell differentiation | ENSAPLP00000003050, ENSAPLP00000015617 |
| striated muscle cell differentiation | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of cell migration | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| positive regulation of kinase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of locomotion | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| wound healing | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000003867 |
| regulation of protein complex assembly | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| regulation of system process | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000012915 |
| negative regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| positive regulation of transferase activity | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002711 |
| regulation of cell motility | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| cotranslational protein targeting to membrane | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| SRP-dependent cotranslational protein targeting to membrane | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| protein targeting to ER | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| protein localization to endoplasmic reticulum | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| establishment of protein localization to endoplasmic reticulum | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| organic substance catabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| embryo development | ENSAPLP00000003050, ENSAPLP00000009200, ENSAPLP00000003219 |
| cell motility | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008674 |
| regulation of cellular component movement | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| localization of cell | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008674 |
| cell differentiation | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007333, ENSAPLP00000015662, ENSAPLP00000002381 |
| regulation of leukocyte activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| RNA localization | ENSAPLP00000013416, ENSAPLP00000015617 |
| ribonucleoside triphosphate biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| nucleobase-containing compound transport | ENSAPLP00000013416, ENSAPLP00000015617 |
| purine nucleoside biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| purine ribonucleoside biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| nucleic acid transport | ENSAPLP00000013416, ENSAPLP00000015617 |
| RNA transport | ENSAPLP00000013416, ENSAPLP00000015617 |
| regulation of cell activation | ENSAPLP00000004358, ENSAPLP00000003050 |
| nuclear export | ENSAPLP00000013416, ENSAPLP00000015617 |
| establishment of RNA localization | ENSAPLP00000013416, ENSAPLP00000015617 |
| macromolecule biosynthetic process | ENSAPLP00000014148, ENSAPLP00000004776, ENSAPLP00000011518, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000014372, ENSAPLP00000016333 |
| cellular macromolecule biosynthetic process | ENSAPLP00000014148, ENSAPLP00000004776, ENSAPLP00000011518, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000011529, ENSAPLP00000014372, ENSAPLP00000016333 |
| cellular process | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000014148, ENSAPLP00000008674, ENSAPLP00000014331, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000015089, ENSAPLP00000002225, ENSAPLP00000014548, ENSAPLP00000011518, ENSAPLP00000003219, ENSAPLP00000016333, ENSAPLP00000013787, ENSAPLP00000000439, ENSAPLP00000003689, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000002381, ENSAPLP00000011000, ENSAPLP00000002711, ENSAPLP00000004030, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620 |
| single-organism cellular process | ENSAPLP00000013787, ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000008674, ENSAPLP00000004776, ENSAPLP00000003689, ENSAPLP00000000439, ENSAPLP00000015662, ENSAPLP00000004358, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000002414, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000002381, ENSAPLP00000011000, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000002711, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007620 |
| cellular biosynthetic process | ENSAPLP00000014148, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000011518, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000014372, ENSAPLP00000016333 |
| protein targeting to membrane | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| protein localization to organelle | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| organelle organization | ENSAPLP00000011000, ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014548, ENSAPLP00000015617, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000002381 |
| catabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| regulation of translation | ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776 |
| apoptotic process | ENSAPLP00000004358, ENSAPLP00000014372, ENSAPLP00000002381 |
| programmed cell death | ENSAPLP00000004358, ENSAPLP00000014372, ENSAPLP00000002381 |
| regulation of cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| aromatic compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000014372, ENSAPLP00000012915 |
| establishment of protein localization to organelle | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular macromolecule catabolic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000014372 |
| cation transport | ENSAPLP00000015679, ENSAPLP00000009300 |
| heart development | ENSAPLP00000003219, ENSAPLP00000002381 |
| nucleoside triphosphate biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| regulation of actin filament polymerization | ENSAPLP00000003050, ENSAPLP00000003219 |
| cell junction organization | ENSAPLP00000003050, ENSAPLP00000008674 |
| muscle cell differentiation | ENSAPLP00000003219, ENSAPLP00000002381 |
| tissue morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of vesicle-mediated transport | ENSAPLP00000003050, ENSAPLP00000002414 |
| macromolecular complex subunit organization | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009200, ENSAPLP00000014372, ENSAPLP00000002381 |
| protein folding | ENSAPLP00000004358, ENSAPLP00000014548, ENSAPLP00000004942 |
| cell death | ENSAPLP00000004358, ENSAPLP00000014372, ENSAPLP00000002381 |
| death | ENSAPLP00000004358, ENSAPLP00000014372, ENSAPLP00000002381 |
| ribosome biogenesis | ENSAPLP00000015617, ENSAPLP00000004776, ENSAPLP00000015662 |
| positive regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| regulation of biological quality | ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000003219, ENSAPLP00000003867, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000015662, ENSAPLP00000002381 |
| organic substance biosynthetic process | ENSAPLP00000014148, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000011518, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000014372, ENSAPLP00000016333 |
| regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000015089, ENSAPLP00000012915 |
| translational initiation | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of phosphorylation | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| protein targeting | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular developmental process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007333, ENSAPLP00000015662, ENSAPLP00000002381 |
| cytoplasmic transport | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000004776, ENSAPLP00000014372 |
| biosynthetic process | ENSAPLP00000014148, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000011518, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000012915, ENSAPLP00000014372, ENSAPLP00000016333 |
| positive regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| cell development | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000002381 |
| purine nucleotide biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| regulation of actin polymerization or depolymerization | ENSAPLP00000003050, ENSAPLP00000003219 |
| purine ribonucleotide biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| nucleoside biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| response to biotic stimulus | ENSAPLP00000002711, ENSAPLP00000002381 |
| positive regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of actin filament length | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of protein polymerization | ENSAPLP00000003050, ENSAPLP00000003219 |
| ribonucleoside biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| negative regulation of transport | ENSAPLP00000003050, ENSAPLP00000002414 |
| purine-containing compound biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| glycosyl compound biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| organic cyclic compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000014372, ENSAPLP00000012915 |
| anatomical structure development | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007333, ENSAPLP00000015662, ENSAPLP00000002381 |
| system process | ENSAPLP00000003219, ENSAPLP00000015089, ENSAPLP00000002381 |
| positive regulation of phosphorylation | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| regulation of protein kinase activity | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| organonitrogen compound biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225, ENSAPLP00000012915 |
| response to stress | ENSAPLP00000003867, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000000447 |
| organ development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000002381 |
| regulation of cytokine production | ENSAPLP00000004358, ENSAPLP00000003050 |
| positive regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000003050 |
| rRNA processing | ENSAPLP00000015617, ENSAPLP00000015662 |
| regulation of nucleoside metabolic process | ENSAPLP00000003219, ENSAPLP00000002414 |
| ribonucleotide biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| rRNA metabolic process | ENSAPLP00000015617, ENSAPLP00000015662 |
| regulation of nucleotide catabolic process | ENSAPLP00000003219, ENSAPLP00000002414 |
| regulation of actin cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of actin filament-based process | ENSAPLP00000003050, ENSAPLP00000003219 |
| regulation of purine nucleotide catabolic process | ENSAPLP00000003219, ENSAPLP00000002414 |
| ribose phosphate biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| positive regulation of multicellular organismal process | ENSAPLP00000004358, ENSAPLP00000003219 |
| epithelium development | ENSAPLP00000003050, ENSAPLP00000015617 |
| muscle structure development | ENSAPLP00000003219, ENSAPLP00000002381 |
| response to abiotic stimulus | ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000014548 |
| nucleobase-containing compound catabolic process | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000014372 |
| nucleobase-containing compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000014372 |
| positive regulation of phosphorus metabolic process | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| positive regulation of phosphate metabolic process | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| aromatic compound catabolic process | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000014372 |
| blood coagulation | ENSAPLP00000003050, ENSAPLP00000003867 |
| hemostasis | ENSAPLP00000003050, ENSAPLP00000003867 |
| regulation of defense response | ENSAPLP00000004358, ENSAPLP00000003050 |
| regulation of cellular component size | ENSAPLP00000003050, ENSAPLP00000003219 |
| coagulation | ENSAPLP00000003050, ENSAPLP00000003867 |
| positive regulation of developmental process | ENSAPLP00000002414, ENSAPLP00000011529 |
| response to wounding | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000003867 |
| multicellular organismal process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000003219, ENSAPLP00000003867, ENSAPLP00000007333, ENSAPLP00000015089, ENSAPLP00000015662, ENSAPLP00000002381 |
| regulation of nucleotide metabolic process | ENSAPLP00000003219, ENSAPLP00000002414 |
| ion transport | ENSAPLP00000015679, ENSAPLP00000009300 |
| nucleocytoplasmic transport | ENSAPLP00000013416, ENSAPLP00000015617 |
| regulation of cellular catabolic process | ENSAPLP00000003219, ENSAPLP00000002414 |
| positive regulation of protein kinase activity | ENSAPLP00000000447, ENSAPLP00000002711 |
| nuclear transport | ENSAPLP00000013416, ENSAPLP00000015617 |
| nitrogen compound transport | ENSAPLP00000013416, ENSAPLP00000015617 |
| regulation of purine nucleotide metabolic process | ENSAPLP00000003219, ENSAPLP00000002414 |
| gene expression | ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000011518, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000014372, ENSAPLP00000016333 |
| transport | ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372 |
| heterocycle biosynthetic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000014372 |
| cellular nitrogen compound biosynthetic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000004776, ENSAPLP00000002225, ENSAPLP00000014372 |
| establishment of localization | ENSAPLP00000013416, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372 |
| regulation of body fluid levels | ENSAPLP00000003050, ENSAPLP00000003867 |
| cardiovascular system development | ENSAPLP00000003219, ENSAPLP00000002381 |
| circulatory system development | ENSAPLP00000003219, ENSAPLP00000002381 |
| regulation of protein phosphorylation | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| translational elongation | ENSAPLP00000009200, ENSAPLP00000004776, ENSAPLP00000014372 |
| ribonucleoprotein complex biogenesis | ENSAPLP00000015617, ENSAPLP00000004776, ENSAPLP00000015662 |
| cellular component morphogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| negative regulation of molecular function | ENSAPLP00000012216, ENSAPLP00000002414, ENSAPLP00000014372 |
| RNA biosynthetic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| localization | ENSAPLP00000013416, ENSAPLP00000008674, ENSAPLP00000011711, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000003050, ENSAPLP00000015679, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000014372 |
| regulation of protein metabolic process | ENSAPLP00000012216, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000002711, ENSAPLP00000004776 |
| M phase | ENSAPLP00000013416, ENSAPLP00000000447 |
| cell migration | ENSAPLP00000003050, ENSAPLP00000008674 |
| ncRNA processing | ENSAPLP00000015617, ENSAPLP00000015662 |
| posttranscriptional regulation of gene expression | ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776 |
| regulation of response to stress | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000014372 |
| single-multicellular organism process | ENSAPLP00000003050, ENSAPLP00000009200, ENSAPLP00000003219, ENSAPLP00000003867, ENSAPLP00000007333, ENSAPLP00000015089, ENSAPLP00000015662, ENSAPLP00000002381 |
| intracellular protein transport | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000002711, ENSAPLP00000004776 |
| system development | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000007333, ENSAPLP00000015662, ENSAPLP00000002381 |
| nucleotide biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| virus-host interaction | ENSAPLP00000013416, ENSAPLP00000002414 |
| regulation of anatomical structure morphogenesis | ENSAPLP00000003050, ENSAPLP00000002414 |
| symbiosis, encompassing mutualism through parasitism | ENSAPLP00000013416, ENSAPLP00000002414 |
| interspecies interaction between organisms | ENSAPLP00000013416, ENSAPLP00000002414 |
| regulation of cytoskeleton organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| interaction with host | ENSAPLP00000013416, ENSAPLP00000002414 |
| nucleoside phosphate biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| regulation of metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000012296, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000002414, ENSAPLP00000011529, ENSAPLP00000014372 |
| positive regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| locomotion | ENSAPLP00000003050, ENSAPLP00000011529, ENSAPLP00000008674 |
| negative regulation of response to stimulus | ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372 |
| organonitrogen compound catabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000009300, ENSAPLP00000009975 |
| single-organism developmental process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000003219, ENSAPLP00000015662, ENSAPLP00000002381 |
| chemical homeostasis | ENSAPLP00000015679, ENSAPLP00000011529 |
| organophosphate biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| cellular protein metabolic process | ENSAPLP00000014148, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000011518, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000014372, ENSAPLP00000016333 |
| cellular aromatic compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000002225, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000012915 |
| homeostatic process | ENSAPLP00000015679, ENSAPLP00000011529, ENSAPLP00000015662 |
| nucleobase-containing small molecule metabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000009300, ENSAPLP00000002225, ENSAPLP00000009975 |
| carbohydrate derivative biosynthetic process | ENSAPLP00000009300, ENSAPLP00000002225 |
| positive regulation of cellular process | ENSAPLP00000013416, ENSAPLP00000002711, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529, ENSAPLP00000014372 |
| protein metabolic process | ENSAPLP00000014148, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000011518, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000014372, ENSAPLP00000016333 |
| developmental process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000003219, ENSAPLP00000015617, ENSAPLP00000007333, ENSAPLP00000015662, ENSAPLP00000002381 |
| organonitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000009300, ENSAPLP00000002225, ENSAPLP00000009975, ENSAPLP00000012915 |
| regulation of catabolic process | ENSAPLP00000003219, ENSAPLP00000002414 |
| cellular response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000014548 |
| biological regulation | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000012296, ENSAPLP00000004358, ENSAPLP00000015679, ENSAPLP00000002414, ENSAPLP00000011529, ENSAPLP00000014372, ENSAPLP00000012915, ENSAPLP00000002381, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000004030, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000003219 |
| protein catabolic process | ENSAPLP00000011529, ENSAPLP00000002711, ENSAPLP00000014548 |
| positive regulation of cellular protein metabolic process | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| multicellular organismal development | ENSAPLP00000003050, ENSAPLP00000009200, ENSAPLP00000003219, ENSAPLP00000007333, ENSAPLP00000015662, ENSAPLP00000002381 |
| organic substance transport | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular membrane organization | ENSAPLP00000011000, ENSAPLP00000003050 |
| anatomical structure formation involved in morphogenesis | ENSAPLP00000003219, ENSAPLP00000002381 |
| membrane organization | ENSAPLP00000011000, ENSAPLP00000003050 |
| organic cyclic compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000002225, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000012915 |
| regulation of primary metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000012296, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000002414, ENSAPLP00000003219, ENSAPLP00000011529, ENSAPLP00000014372 |
| cellular macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000014372, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000011518, ENSAPLP00000007620, ENSAPLP00000016333 |
| protein transport | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000004776, ENSAPLP00000014372 |
| response to chemical stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000003867, ENSAPLP00000002711, ENSAPLP00000014548 |
| nucleobase-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000002225, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| establishment of protein localization | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular protein localization | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular macromolecule localization | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| ncRNA metabolic process | ENSAPLP00000015617, ENSAPLP00000015662 |
| negative regulation of catalytic activity | ENSAPLP00000012216, ENSAPLP00000002414 |
| nucleic acid metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000014372 |
| cellular response to chemical stimulus | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002711, ENSAPLP00000014548 |
| regulation of cell death | ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000014372 |
| regulation of protein modification process | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| regulation of apoptotic process | ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000014372 |
| regulation of programmed cell death | ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000014372 |
| RNA metabolic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000014372 |
| regulation of organelle organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| nitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000002225, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000012915 |
| cellular component biogenesis | ENSAPLP00000003050, ENSAPLP00000003867, ENSAPLP00000015617, ENSAPLP00000008674, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000014548 |
| positive regulation of protein metabolic process | ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| positive regulation of biological process | ENSAPLP00000013416, ENSAPLP00000002711, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000003219, ENSAPLP00000000447, ENSAPLP00000011529, ENSAPLP00000014372 |
| cell cycle phase | ENSAPLP00000013416, ENSAPLP00000000447 |
| regulation of multicellular organismal development | ENSAPLP00000003050, ENSAPLP00000002414 |
| heterocycle metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000002225, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| positive regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002414 |
| regulation of developmental process | ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000011529 |
| cellular localization | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000004776, ENSAPLP00000014372 |
| intracellular transport | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000004776, ENSAPLP00000014372 |
| mitotic cell cycle | ENSAPLP00000013416, ENSAPLP00000000447 |
| response to external stimulus | ENSAPLP00000003050, ENSAPLP00000002711 |
| negative regulation of signal transduction | ENSAPLP00000002414, ENSAPLP00000002711 |
| immune system process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000015662 |
| regulation of localization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000011529 |
| mRNA metabolic process | ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular nitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000002225, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000007620, ENSAPLP00000009300, ENSAPLP00000014372, ENSAPLP00000009975 |
| regulation of cell cycle | ENSAPLP00000000447, ENSAPLP00000002414 |
| purine nucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| purine ribonucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| anatomical structure morphogenesis | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002381 |
| cellular response to organic substance | ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000014548 |
| regulation of cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000012296, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000002414, ENSAPLP00000014372 |
| macromolecule localization | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000004776, ENSAPLP00000014372 |
| response to organic substance | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002711, ENSAPLP00000014548 |
| response to stimulus | ENSAPLP00000013416, ENSAPLP00000013159, ENSAPLP00000003867, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004942, ENSAPLP00000004030, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002381 |
| macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000014372, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000011518, ENSAPLP00000007620, ENSAPLP00000016333 |
| ribonucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| purine nucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| purine ribonucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| regulation of immune system process | ENSAPLP00000004358, ENSAPLP00000003050 |
| negative regulation of cell communication | ENSAPLP00000002414, ENSAPLP00000002711 |
| negative regulation of signaling | ENSAPLP00000002414, ENSAPLP00000002711 |
| establishment of localization in cell | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000015617, ENSAPLP00000004776, ENSAPLP00000014372 |
| cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000012915, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000002711, ENSAPLP00000002225, ENSAPLP00000014548, ENSAPLP00000011518, ENSAPLP00000007620, ENSAPLP00000016333 |
| nucleoside triphosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| cell projection organization | ENSAPLP00000003050, ENSAPLP00000003219 |
| chromosome organization | ENSAPLP00000012216, ENSAPLP00000000447 |
| response to oxygen-containing compound | ENSAPLP00000003219, ENSAPLP00000014548 |
| protein localization | ENSAPLP00000013416, ENSAPLP00000009200, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000004776, ENSAPLP00000014372 |
| ribonucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| regulation of response to stimulus | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372 |
| signal transduction | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000013159, ENSAPLP00000002414, ENSAPLP00000003867, ENSAPLP00000002711 |
| negative regulation of cellular process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372, ENSAPLP00000012296 |
| purine nucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| nucleoside metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| purine ribonucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| purine-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| glycosyl compound metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| proteolysis involved in cellular protein catabolic process | ENSAPLP00000002711, ENSAPLP00000014548 |
| ribonucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| ribose phosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| primary metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000012915, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000002711, ENSAPLP00000002225, ENSAPLP00000014548, ENSAPLP00000011518, ENSAPLP00000007620, ENSAPLP00000016333 |
| cellular macromolecular complex assembly | ENSAPLP00000003867, ENSAPLP00000015617 |
| cellular protein catabolic process | ENSAPLP00000002711, ENSAPLP00000014548 |
| negative regulation of nucleobase-containing compound metabolic process | ENSAPLP00000014372, ENSAPLP00000012296 |
| GTP metabolic process | ENSAPLP00000013416, ENSAPLP00000002225 |
| negative regulation of nitrogen compound metabolic process | ENSAPLP00000014372, ENSAPLP00000012296 |
| guanosine-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000002225 |
| cellular component assembly | ENSAPLP00000003050, ENSAPLP00000003867, ENSAPLP00000015617, ENSAPLP00000008674, ENSAPLP00000014548 |
| signaling | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000013159, ENSAPLP00000002414, ENSAPLP00000003867, ENSAPLP00000002711 |
| single organism signaling | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000013159, ENSAPLP00000002414, ENSAPLP00000003867, ENSAPLP00000002711 |
| positive regulation of metabolic process | ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| negative regulation of cellular metabolic process | ENSAPLP00000002414, ENSAPLP00000014372, ENSAPLP00000012296 |
| regulation of cellular component organization | ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414 |
| cellular response to stimulus | ENSAPLP00000013416, ENSAPLP00000013159, ENSAPLP00000003867, ENSAPLP00000002711, ENSAPLP00000014548, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000003219 |
| positive regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000002414 |
| positive regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000002414 |
| positive regulation of signaling | ENSAPLP00000003050, ENSAPLP00000002414 |
| cell communication | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000013416, ENSAPLP00000013159, ENSAPLP00000002414, ENSAPLP00000003867, ENSAPLP00000002711 |
| negative regulation of biological process | ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372, ENSAPLP00000012296 |
| purine nucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| nucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| purine nucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| nucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| ribonucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| purine ribonucleoside triphosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| cell cycle process | ENSAPLP00000013416, ENSAPLP00000000447 |
| ribonucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| purine ribonucleoside catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| glycosyl compound catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| organic substance metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000012915, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000002711, ENSAPLP00000002225, ENSAPLP00000014548, ENSAPLP00000011518, ENSAPLP00000007620, ENSAPLP00000016333 |
| RNA processing | ENSAPLP00000015617, ENSAPLP00000014331, ENSAPLP00000015662 |
| purine nucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| DNA metabolic process | ENSAPLP00000013416, ENSAPLP00000012216 |
| purine ribonucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| nucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| ribonucleotide catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| organophosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| purine-containing compound catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| nucleoside phosphate catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| small molecule metabolic process | ENSAPLP00000013416, ENSAPLP00000007333, ENSAPLP00000009300, ENSAPLP00000002225, ENSAPLP00000009975, ENSAPLP00000012915 |
| carbohydrate derivative catabolic process | ENSAPLP00000013416, ENSAPLP00000009300 |
| nucleoside phosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| nucleotide metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| carbohydrate derivative metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| negative regulation of macromolecule metabolic process | ENSAPLP00000002414, ENSAPLP00000014372, ENSAPLP00000012296 |
| nervous system development | ENSAPLP00000003050, ENSAPLP00000007333 |
| regulation of transport | ENSAPLP00000003050, ENSAPLP00000002414 |
| single-organism metabolic process | ENSAPLP00000013416, ENSAPLP00000011529, ENSAPLP00000007333, ENSAPLP00000009300, ENSAPLP00000002225, ENSAPLP00000009975, ENSAPLP00000012915 |
| negative regulation of metabolic process | ENSAPLP00000002414, ENSAPLP00000014372, ENSAPLP00000012296 |
| organophosphate metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| positive regulation of cellular metabolic process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| regulation of biological process | ENSAPLP00000013416, ENSAPLP00000003867, ENSAPLP00000004776, ENSAPLP00000012296, ENSAPLP00000004358, ENSAPLP00000002414, ENSAPLP00000011529, ENSAPLP00000014372, ENSAPLP00000012915, ENSAPLP00000013159, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000015089, ENSAPLP00000014548, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000007620, ENSAPLP00000003219 |
| positive regulation of macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000000447, ENSAPLP00000002414, ENSAPLP00000002711 |
| metabolic process | ENSAPLP00000013416, ENSAPLP00000014148, ENSAPLP00000014331, ENSAPLP00000004776, ENSAPLP00000015662, ENSAPLP00000004942, ENSAPLP00000004358, ENSAPLP00000009200, ENSAPLP00000015617, ENSAPLP00000011529, ENSAPLP00000009300, ENSAPLP00000009975, ENSAPLP00000014372, ENSAPLP00000012915, ENSAPLP00000012216, ENSAPLP00000007333, ENSAPLP00000002711, ENSAPLP00000002225, ENSAPLP00000014548, ENSAPLP00000011518, ENSAPLP00000007620, ENSAPLP00000016333 |
| regulation of macromolecule metabolic process | ENSAPLP00000013416, ENSAPLP00000012216, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000012296, ENSAPLP00000007620, ENSAPLP00000002414, ENSAPLP00000000447, ENSAPLP00000014372 |
| cell surface receptor signaling pathway | ENSAPLP00000003050, ENSAPLP00000013159, ENSAPLP00000002414 |
| cell cycle | ENSAPLP00000013416, ENSAPLP00000000447 |
| cellular response to stress | ENSAPLP00000003219, ENSAPLP00000002711 |
| regulation of signal transduction | ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000002711 |
| proteolysis | ENSAPLP00000002711, ENSAPLP00000014548 |
| regulation of biosynthetic process | ENSAPLP00000013416, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000011529, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of nucleobase-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372, ENSAPLP00000012296 |
| regulation of cell communication | ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000002711 |
| regulation of cellular macromolecule biosynthetic process | ENSAPLP00000013416, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of nitrogen compound metabolic process | ENSAPLP00000013416, ENSAPLP00000003219, ENSAPLP00000002414, ENSAPLP00000002711, ENSAPLP00000014372, ENSAPLP00000012296 |
| regulation of signaling | ENSAPLP00000003050, ENSAPLP00000002414, ENSAPLP00000002711 |
| regulation of gene expression | ENSAPLP00000013416, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372, ENSAPLP00000012296 |
| macromolecular complex assembly | ENSAPLP00000003867, ENSAPLP00000015617 |
| regulation of macromolecule biosynthetic process | ENSAPLP00000013416, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| regulation of cellular process | ENSAPLP00000013416, ENSAPLP00000013159, ENSAPLP00000003867, ENSAPLP00000002711, ENSAPLP00000004776, ENSAPLP00000014548, ENSAPLP00000012296, ENSAPLP00000004358, ENSAPLP00000003050, ENSAPLP00000000447, ENSAPLP00000003219, ENSAPLP00000007620, ENSAPLP00000002414, ENSAPLP00000011529, ENSAPLP00000014372 |
| regulation of cellular biosynthetic process | ENSAPLP00000013416, ENSAPLP00000002414, ENSAPLP00000007620, ENSAPLP00000004776, ENSAPLP00000014372 |
| phosphorus metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| phosphate-containing compound metabolic process | ENSAPLP00000013416, ENSAPLP00000009300, ENSAPLP00000002225 |
| regulation of RNA metabolic process | ENSAPLP00000013416, ENSAPLP00000014372, ENSAPLP00000012296 |
| regulation of transcription, DNA-dependent | ENSAPLP00000013416, ENSAPLP00000014372 |
| regulation of RNA biosynthetic process | ENSAPLP00000013416, ENSAPLP00000014372 |
|